Ginkgo Bioworkss

DNA

Biotech

Health Care

Stocks Under $10

Country

US

Industry

Health Care

Market Cap

Mid Cap

Num. Employees

1292

IPO Date

Apr 19, 2021

Create Alert

DNA

Country

US

Industry

Health Care

Biotech

Health Care

+1

Create Alert

Ginkgo Bioworks Holdings, Inc. is a biotech company. The company is headquartered in Boston, Massachusetts and currently employs 1,292 full-time employees. The company went IPO on 2021-04-19. Its cell programs are designed to enable biological production of products as diverse as therapeutics, key food ingredients and chemicals derived from petroleum. Its Foundry segment consists of research and development services performed under collaboration and license agreements relating to its cell programming platform. Its cell programming platform includes two assets: the Foundry, biology lab facilities, enabled by investment in workflows, custom software, robotic automation, and data science and analytics. Its Biosecurity segment consists of COVID-19 testing products and services primarily provided to public health authorities. The company also owns the adeno-associated virus capsid discovery and engineering platform assets.